Integrating the requirements of 21 CFR 820 into a product development process is challenging. Done poorly, it drags down the design process and puts you at risk. Done well, it delivers quality products, resource efficiencies and compliance that are easily demonstrated to the FDA.
You can’t afford to be in a position where either design controls or the product development process are weak. Design controls are essential to safety and effectiveness. The FDA reports ineffective design controls are the root cause of as many as 31% of recalls. Ineffective product development processes are slow, costly and often miss significant business objectives.
This seminar on quality system regulations for medical devices will show you how to build a best practice stage gate product development process that not just incorporates 21 CFR 820 design controls but keeps you ahead of the competition and easily shows compliance during an audit. The process showcased in this course will also fulfill QSR requirements, produce the objective evidence necessary to prove compliance, manage resources and deliver quality products.